SUBSCRIBE
SUBSCRIBE
News   Business

Genelabs Technologies, Inc. Provides Update on Hepatitis C Drug Development with Collaboration Partners

June 23, 2008 | 
1 min read
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB) announced today that based on progress to date, its hepatitis C drug development and commercialization collaboration with Novartis is continuing to the next phase.
Alliances
Novartis
MORE ON THIS TOPIC
Company downsizing, staff reduction and layoffs. Employee dismissal, firing and unemployment. Business concept.
Layoffs
InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot
January 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Trendy halftone business concept collage. Idea concept, business concept, financial planning,financial profit, favorable conditions, favorable conditions. Trendy modern retro illustration in bright trendy colors. Vector illustration
Mergers & acquisitions
Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie
January 9, 2026
 · 
1 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Tessera Trimming 90 Employees as Part of Pipeline Prioritization
January 8, 2026
 · 
99 min read
 · 
BioSpace Editorial Staff
Trendy halftone business concept collage. Idea concept, business concept, financial planning,profit, earnings. Trendy modern retro illustration. Vector illustration
Venture capital
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
January 8, 2026
 · 
2 min read
 · 
Tristan Manalac